Tel:
Email:

ASO Library Synthesis Service

Comprehensive ASO Libraries for Target Discovery & Validation

We specialize in high-quality antisense oligonucleotide (ASO) library synthesis, offering researchers and biotech companies reliable, scalable, and customizable solutions for drug discovery, gene silencing, functional genomics, and drug target validation. With advanced synthesis platforms, rigorous quality control, and expert bioinformatics support, our service ensures precise sequence design, fast turnaround, and reproducible results for your ASO projects. Utilizing advanced chemically modified oligonucleotides, we enable efficient and specific mRNA targeting to accelerate therapeutic development and mechanistic studies.

Problems We Solve

Low Yield in ASO Synthesis: Traditional synthesis methods often produce ASOs with low yield and inconsistent quality. Our optimized protocols ensure high-yield production with exceptional purity for every oligonucleotide in your library.

Poor Target Specificity: Ineffective sequence design can lead to off-target effects and reduced knockdown efficiency. We use advanced bioinformatics to design ASOs with superior target specificity and minimal cross-reactivity.

High Screening Costs: Large-scale ASO screening can be expensive and time-consuming. Our high-throughput synthesis capabilities significantly reduce per-sample cost while maintaining consistent quality across the library.

Limited Scalability: Scaling from pilot studies to high-throughput applications is a challenge for many labs. Our platform supports seamless scalability, enabling you to expand your ASO projects without compromising performance.

Lack of Chemical Modification Options: Some suppliers offer limited modification capabilities, restricting ASO stability and efficacy. We provide a full range of backbone and sugar modifications to enhance binding affinity and in vivo performance.

Our Antisense Oligonucleotide Library Synthesis Service

By combining technical expertise with state-of-the-art synthesis platforms, we help you streamline your ASO research and bring your therapeutic or diagnostic projects closer to success.

Custom ASO Design & Bioinformatics Support

Target-specific sequence design, off-target analysis, and secondary structure prediction.

High-Throughput ASO Synthesis

Parallel synthesis of hundreds to thousands of oligonucleotides with precise control over length, modifications, and purity.

Chemical Modifications

Wide range of backbone and sugar modifications (e.g., phosphorothioate, 2′-O-Me, LNA) to enhance stability and binding affinity.

Quality Control & Validation

HPLC and mass spectrometry analysis, purity reports, and functional validation options.

Scalable Production

From small pilot libraries to large-scale screening collections.

Fast Turnaround

Optimized workflows for rapid delivery without compromising quality.

Step-by-Step Breakdown of Our ASO Library Synthesis Service

1Target Selection

Specify gene(s) or mRNA regions of interest.

2Library Design

Custom ASO sequences with optimal modifications.

3Synthesis & QC

High-throughput synthesis with stringent quality control.

4Delivery

Purified, ready-to-use ASO libraries in scalable formats.

Key Features of Our ASO Libraries

  • High-Coverage Design: Libraries are tailored to target entire genes or specific mRNA regions (e.g., exons, splice sites, UTRs) for systematic screening.
  • Chemical Modifications: Incorporation of phosphorothioate (PS) backbones, 2'-O-methyl (2'-OMe), or 2'-O-methoxyethyl (2'-MOE) modifications to enhance stability, binding affinity, and nuclease resistance.
  • Gapmer & Mixed-Chemistry Designs: Optimized RNase H-dependent (Gapmer) and steric-blocking (non-Gapmer) ASOs for different mechanistic approaches.
  • Validated Efficacy: Libraries are screened for optimal mRNA binding and knockdown efficiency, as demonstrated in studies such as *Eg5 (kinesin-like 1) validation for antineoplastic drug development*.

Applications of ASO Library Synthesis

Target Identification & Validation

Systematic screening to identify druggable mRNA regions, as shown in TNFα mRNA cleavage optimization.

Functional Genomics

Rapid assessment of gene function in in vitro and in vivo models.

Therapeutic Development

Support for monogenic disorder treatments through precise ASO-mediated gene modulation.

Case Study Applications

Proven utility in gene functionalization and drug target validation.

FAQs about ASO Library Synthesis

FAQs about sgRNA Services

Accelerate Your Research with Our ASO Library Synthesis Service

Unlock the full potential of your genetic research and therapeutic discovery with our custom Antisense Oligonucleotide library synthesis solutions. Whether you need a small-scale pilot set or a high-throughput screening library, we deliver precision-designed, high-purity ASOs tailored to your specific targets—fast, reliable, and ready for action. Partner with us to streamline your workflow, reduce costs, and achieve consistent, reproducible results. Contact us today to request a free consultation or a custom quote, and take the next step toward advancing your ASO-based innovations.

References

  1. Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug development. DOI: 10.1158/0008-5472.CAN-05-1531
  2. Possibilities and limitations of antisense oligonucleotide therapies for monogenic disorders. DOI:10.1038/s43856-023-00419-1
  3. Determination of optimal sites of antisense oligonucleotide cleavage within TNFα mRNA. doi: 10.1093/nar/29.17.3664
  4. Case study: use of a library of antisense inhibitors for gene functionalization and drug target validation. https://doi.org/10.1016/S1741-8372(04)02430-2
Online Inquiry
Verification code
Inquiry Basket